LGND
NASDAQ · Pharmaceuticals
Ligand Pharmaceuticals
$295.92
+11.01 (+3.86%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+51.63%
1Y
+155.79%
YTD
+55.66%
Open$288.34
Previous Close$284.91
Day High$300.12
Day Low$288.34
52W High$276.20
52W Low$110.00
Volume—
Avg Volume267.4K
Market Cap5.51B
P/E Ratio35.87
EPS$7.42
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$193.47
Above
SMA 200
$162.08
Above
RSI (14)
38.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
14 analysts
Price Target
-89.3% upside
Current
$295.92
$295.92
Target
$31.56
$31.56
$18.80
$31.56 avg
$35.41
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 264.75M | 238.57M | 944.72M |
| Net Income | 122.90M | 99.68M | 258.92M |
| Profit Margin | 46.4% | 44.1% | 27.4% |
| EBITDA | 72.79M | 62.32M | 346.84M |
| Free Cash Flow | — | — | 167.31M |
| Rev Growth | +11.0% | +11.0% | +8.5% |
| Debt/Equity | 0.44 | 0.44 | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,127.69 | +0.93% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $244.88 | +1.61% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $125.45 | +4.02% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $23.67 | -1.54% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.39 | +0.71% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $77.82 | -0.45% | 12.5 | 33.00B |